The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Efficacy and Safety of Paroxetine Treatment for Chronic PTSD: A Fixed-Dose, Placebo-Controlled Study
Abstract
OBJECTIVE: This study evaluated the efficacy and safety of paroxetine for the treatment of patients with chronic posttraumatic stress disorder (PTSD). METHOD: Outpatients with chronic PTSD according to DSM-IV criteria and a score of 50 or more on the Clinician-Administered PTSD Scale, part 2, were randomly assigned to take placebo (N=186), 20 mg/day of paroxetine (N=183), or 40 mg/day of paroxetine (N=182) for 12 weeks. Efficacy was assessed by examining the change in total score from baseline to endpoint on the Clinician-Administered PTSD Scale, part 2, and rates of response ("very much improved" or "much improved") for global improvement on the Clinical Global Impression scale. RESULTS: Paroxetine-treated patients in both dose groups demonstrated significantly greater improvement on primary outcome measures compared to placebo-treated patients in the intent-to-treat analysis. Moreover, paroxetine treatment resulted in statistically significant improvement compared to placebo on all three PTSD symptom clusters (reexperiencing, avoidance/numbing, and hyperarousal), social and occupational impairment, and comorbid depression. Paroxetine was effective for both men and women. Treatment response did not vary by trauma type, time since trauma, or severity of baseline PTSD or depressive symptoms. Both doses were well tolerated. CONCLUSIONS: Doses of 20 and 40 mg/day of paroxetine are effective and well tolerated in the treatment of adults with chronic PTSD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Posttraumatic Stress Disorder in the National Comorbidity Survey
Kessler, R. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240066012 · Cited by 10,379
A sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Janavs, J., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83296-8 · Cited by 3,513
(2008) · The Concise Encyclopedia of Statistics · doi:10.1007/978-0-387-32833-1_5 · Cited by 2,670
Clinician-administered PTSD scale: A review of the first ten years of research
Weathers, F. W., Keane, T. M., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1029 · Cited by 1,901
The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders
Heim, C., Ehlert, U., & Hellhammer, D. H. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00035-9 · Cited by 1,688
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Assessment of a new self-rating scale for post-traumatic stress disorder
DAVIDSON, J. R. T., BOOK, S. W., COLKET, J. T., TUPLER, L. A., ROTH, S., DAVID, D., HERTZBERG, M., MELLMAN, T., BECKHAM, J. C., SMITH, R. D., et al. (1997) · Psychological Medicine · doi:10.1017/s0033291796004229 · Cited by 977
Post-traumatic stress disorder in the community: an epidemiological study
Davidson, J. R. T., Hughes, D., Blazer, D. G., & George, L. K. (1991) · Psychological Medicine · doi:10.1017/s0033291700022352 · Cited by 969
Foa, E. B., Dancu, C. V., Hembree, E. A., Jaycox, L. H., Meadows, E. A., & Street, G. P. (1999) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.67.2.194 · Cited by 808
Brady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., Sikes, C. R., & Farfel, G. M. (2000) · JAMA · doi:10.1001/jama.283.14.1837 · Cited by 690
Non-parametric Statistical Methods
Gastwirth, J. L. (1990) · Time Series and Statistics · doi:10.1007/978-1-349-20865-4_24 · Cited by 514
Fluoxetine in post‐traumatic stress disorder
Davidson, J., Roth, S., & Newman, E. (1991) · Journal of Traumatic Stress · doi:10.1002/jts.2490040309 · Cited by 412
Fluoxetine in post-traumatic stress disorder: Randomised, double-blind study
Connor, K. M., Sutherland, S. M., Tupler, L. A., Malik, M. L., Jonathan, R., & Davidson, T. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.17 · Cited by 353
Stein, M. B., Liebowitz, M. R., Lydiard, R. B., Pitts, C. D., Bushnell, W., & Gergel, I. (1998) · JAMA · doi:10.1001/jama.280.8.708 · Cited by 348
Physical symptoms in post-traumatic stress disorder
Mcfarlane, A. C., Atchison, M., Rafalowicz, E., & Papay, P. (1994) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)90024-8 · Cited by 343
Prevalence of Symptoms of Posttraumatic Stress Disorder in German Professional Firefighters
Wagner, D., Heinrichs, M., & Ehlert, U. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.12.1727 · Cited by 323
Noradrenergic and Serotonergic Function in Posttraumatic Stress Disorder
Southwick, S. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200083012 · Cited by 321
Paroxetine versus Clomipramine in the Treatment of Obsessive–Compulsive Disorder
Zohar, J., Judge, R., & Ocd Paroxetine Study Investigators (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.4.468 · Cited by 272
A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.10.1289 · Cited by 259
Posttraumatic Stress Disorder and Comorbid Major Depression
Blanchard, E. B., Buckley, T. C., Hickling, E. J., & Taylor, A. E. (1998) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(97)00047-9 · Cited by 258
Pharmacotherapy for Posttraumatic Stress Disorder Using Phenelzine or Imipramine
KOSTEN, T. R., FRANK, J. B., DAN, E., McDOUGLE, C. J., & GILLER, E. L. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199106000-00011 · Cited by 238
Brady, L. S., Gold, P. W., Herkenham, M., Lynn, A. B., & Whitfield, H. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)90459-m · Cited by 235
Double-Blind, Fixed-Dose, Placebo-Controlled Study of Paroxetine in the Treatment of Panic Disorder
Ballenger, J. C., Wheadon, D. E., Steiner, M., Bushnell, W., & Gergel, I. P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.1.36 · Cited by 220
The effects of neonatal stress on brain development: implications for psychopathology
GRAHAM, Y. P., HEIM, C., GOODMAN, S. H., MILLER, A. H., & NEMEROFF, C. B. (1999) · Development and Psychopathology · doi:10.1017/s0954579499002205 · Cited by 197
Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety
Kent, J. M., Coplan, J. D., & Gorman, J. M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00210-8 · Cited by 196
Ferrada‐Noli, M., Asberg, M., Ormstad, K., Lundin, T., & Sundbom, E. (1998) · Journal of Traumatic Stress · doi:10.1023/a:1024461216994 · Cited by 180
Reul, J. M. H. M., Labeur, M. S., Grigoriadis, D. E., De Souza, E. B., & Holsboer, F. (1994) · Neuroendocrinology · doi:10.1159/000126788 · Cited by 174
Marshall, R. D., Schneier, F. R., Fallon, B. A., Knight, C., Abbate, L. A., Goetz, D. M., Campeas, R. B., & Liebowitz, M. R. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199802000-00003 · Cited by 166
Self-citationLack of Efficacy for Fluoxetine in PTSD: A Placebo Controlled Trial in Combat Veterans
Hertzberg, M. A., Feldman, M. E., Beckham, J. C., Kudler, H. S., & Davidson, J. R. T. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009076231175 · Cited by 161
Obstacles in Implementing Exposure Therapy for PTSD: Case Discussions and Practical Solutions
Jaycox, L. H., & Foa, E. B. (1996) · Clinical Psychology & Psychotherapy · doi:10.1002/(sici)1099-0879(199609)3:3<176::aid-cpp100>3.0.co;2-1 · Cited by 144
Sheehan, D. V., Raj, A. B., Harnett-Sheehan, K., Soto, S., & Knapp, E. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03405.x · Cited by 86
The Anti-anxiety and Anti-agitation Effects of Paroxetine in Depressed Patients
Dunbar, G. C., & Fuell, D. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199206004-00014 · Cited by 33
Marshall, R. D., & Cloître, M. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0078-3 · Cited by 23
Self-citationFurther psychometric assessment of the TOP-8: A brief interview-based measure of PTSD
Connor, K. M., & Davidson, J. R. T. (1999) · Depression and Anxiety · Cited by 21
Yehuda, R. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4177-6_19 · Cited by 10
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
What Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Traumatic stress: effects on the brain
Bremner, J. D. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.4/jbremner · Cited by 738
Posttraumatic stress disorder: a state-of-the-science review
Nemeroff, C. B., Bremner, J. D., Foa, E. B., Mayberg, H. S., North, C. S., & Stein, M. B. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.005 · Cited by 675
Metadata
- Authors
- Marshall, R. D., Beebe, K. L., Oldham, M., & Zaninelli, R.
- Venue
- American Journal of Psychiatry
- Published
- 2001-12-01
- Volume
- 158
- Issue
- 12
- Pages
- 1982-1988
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2102215436
- Cited by
- 432
- References
- 37
- FWCI
- 29.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.